India, Aug. 4 -- image credit- shutterstock

Alveolus Bio, a US-based respiratory drug development biotech company founded byDr.Vivek LalfromUniversity of Alabama at Birmingham,has announced a strategic financing round led by Raichur-basedShilpa Medicare Limited, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.

Through this collaboration,Shilpa Biologics, the biologics arm of Shilpa Medicare, will become Alveolus Bio's exclusive global development and manufacturing partner.

This partnership propels Alveolus Bio'slive biotherapeutics and small molecule platformtowardsPhase 2andfirst-in-human clinical trials, with a lead asset forChronic obstructive ...